Prognostic value of neutrophil-to-lymphocyte ratio in patients with glioblastoma

被引:16
作者
Alexiou, George A. [1 ]
Vartholomatos, Evrysthenis [1 ]
Voulgaris, Spyridon [1 ]
机构
[1] Univ Hosp Ioannina, Ioannina 45500, Greece
关键词
Temozolomide; Full Blood Count; Glioblastoma Patient; Brain Tumor Patient; ECOG Performance Status;
D O I
10.1007/s11060-013-1240-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:521 / 522
页数:2
相关论文
共 3 条
[1]   The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme [J].
Bambury, R. M. ;
Teo, M. Y. ;
Power, D. G. ;
Yusuf, A. ;
Murray, S. ;
Battley, J. E. ;
Drake, C. ;
O'Dea, P. ;
Bermingham, N. ;
Keohane, C. ;
Grossman, S. A. ;
Moylan, E. J. ;
O'Reilly, S. .
JOURNAL OF NEURO-ONCOLOGY, 2013, 114 (01) :149-154
[2]  
Guthrie GJ, 2013, CRIT REV ONCOL HEMAT, DOI [10.1016/j.critrevonc.2013.03.010, DOI 10.1016/J.CRITREV0NC.2013.03.010]
[3]   Characterization of Cytokine-Induced Myeloid-Derived Suppressor Cells from Normal Human Peripheral Blood Mononuclear Cells [J].
Lechner, Melissa G. ;
Liebertz, Daniel J. ;
Epstein, Alan L. .
JOURNAL OF IMMUNOLOGY, 2010, 185 (04) :2273-2284